Bladder cancer: open trials in Canada

42 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Marengo Therapeutics, Inc.
Princess Margaret Cancer Centre, Toronto
Registry updated 2026-08-11
NCT04752722
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Trial Treatment · Phase 1/2 · enGene, Inc.
Prostate Cancer Centre, Calgary · Nova Scotia Health Authority, Halifax · McGill University Health Center - Glen site, Montreal · CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal · University Health Network - Princess Margaret Cancer Centre, Toronto · Vancouver Prostate Centre, Vancouver
Registry updated 2026-08-07
NCT06124976
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Trial Treatment · Phase 2/3 · Peter Black
Centre of Applied Urology Research/Nova Scotia Health Authority, Halifax · London Health Sciences Centre · Victoria Hospital, London · Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal · McGill University Health Center, Montreal · Centre de recherche du CHUS, Sherbrooke · UHN Princess Margaret Cancer Centre, Toronto · Vancouver Prostate Centre, Vancouver · Men's Health Clinic, Winnipeg
Registry updated 2026-08-03
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Edmonton · McGill University Health Centre, Montreal · The Ottawa Hospital Cancer Centre, Ottawa · Princess Margaret Cancer Centre, Toronto
Registry updated 2026-07-29
NCT05503797
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Trial Treatment · Phase 2 · Fore Biotherapeutics
Centre Hospitalier Universitaire Sainte-Justine, Montreal · Sunny brook Health Sciences Centre- Bayview Campus, Toronto
Registry updated 2026-07-27
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Jewish General Hospital, Montreal · Centre integre universitaire de sante et de services sociaux de l'Estrie, Sherbrooke · BC Cancer - Vancouver Fairmont Medical Building, Vancouver · BC Cancer - Vancouver, Vancouver · CancerCare Manitoba, Winnipeg
Registry updated 2026-07-22
NCT07720284
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Trial Treatment · Phase 3 · AstraZeneca
Abbotsford British Columbia · Barrie · Calgary · Hamilton · Kingston · London · Mississauga · Montreal
Registry updated 2026-07-22
NCT07420517
Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Paul Toren
CHU de Quebec-Universite Laval, Québec
Registry updated 2026-03-30
NCT05037279
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
Trial Treatment · Phase 3 · Verity Pharmaceuticals Inc.
Kingston · Montreal · Toronto · Toronto · Toronto · Vancouver
Registry updated 2026-03-20
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Research · UMC Utrecht
University Health Network - Princess Margaret Cancer Center, Toronto · Sunnybrook Health Sciences Centre - Odette Cancer Centre, Toronto
Registry updated 2026-03-05
NCT03945162
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Trial Treatment · Phase 2 · Theralase® Technologies Inc.
Site 01-004 - Nova Scotia Health Authority - Centre for Applied Urology Research, Halifax · Site 01-014 - St. Joseph's Healthcare, Hamilton · Site 01-002- London Health Sciences Centre - Victoria Hospital, London · Site 01-003 - McGill University Health Centre - Glen-Cedars Cancer Centre, Montreal · Site 01-001 - University Health Network - Princess Margaret Cancer Centre, Toronto · Site 01-005 - The Vancouver Prostate Centre - Diamond Health Care Centre - Vancouver General Hospital, Vancouver
Registry updated 2025-11-24
NCT06218433
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
Trial Treatment · Tampere University Hospital
Vancouver Prostate Centre, Vancouver
Registry updated 2025-11-18
NCT06310759
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Research · Tampere University Hospital
Vancouver Prostate Centre, Vancouver
Registry updated 2025-10-10
NCT07204301
Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Patients: A Randomized Controlled Trial and Observational Study
Trial Treatment · Western University, Canada
Victoria Hospital - London Health Sciences Center, London
Registry updated 2025-10-02
NCT06537154
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
Trial Treatment · Phase 2/3 · Peter Black
Vancouver Prostate Centre, Vancouver
Registry updated 2025-07-30
NCT07064863
A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.
Trial Treatment · Phase 1/2 · Queen's University
Kingston Health Sciences Center, Kingston
Registry updated 2025-07-17
NCT06595446
A Feasibility Randomized Trial Evaluating Early vs Late Stent Removal Following Radical Cystectomy and Ileal Conduit Formation for Bladder Cancer
Trial Treatment · Western University, Canada
Victoria Hospital, London
Registry updated 2025-04-04

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error